Congress’ Oxycontin concerns continue
Reps. Frank Wolf (R-Va), Jim Greenwood (R- Pa), Henry Bonilla (R-Texas) and Harold Rogers (R- Ky) meet with FDA Commissioner McClellan April 3 to discuss abuse of Purdue's OxyContin (oxycodone). Wolf sent a letter to HHS Secretary Thompson March 28 asking that OxyContin treatment be limited to patients with severe pain. The House Energy & Commerce committee is investigating OxyContin and Purdue's Palladone, a pain therapy pending at FDA (1"The Pink Sheet" March 3, p. 33)...
You may also be interested in...
Purdue Pharma will submit documents relating to risk management for its pending pain therapy Palladone to the House Energy & Commerce Committee
Three years after rebranding from Concordia, Advanz Pharma is to be swallowed up by European-focused private equity Nordic Capital.
The goal is to create a program which mass sequences SARS-CoV-2 samples in order to detect new variants, with £30m injected into the UK's hub for genomic sequencing in Cambridge.